Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest
The Life Sciences Innovative Manufacturing Fund supports businesses investing in life sciences manufacturing projects in the UK.
From: Department for Science, Innovation and Technology and Office for Life Sciences
Published: 2 March 2022
Last updated: 5 September 2025 — See all updates
Documents
- Life Sciences Innovative Manufacturing Fund (LSIMF): application guide (HTML)
- Life Sciences Innovative Manufacturing Fund (LSIMF): privacy notice (HTML)
Details
31 October 2024: update
The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis.
The government has committed up to £520 million for life sciences manufacturing, to help deliver on the government's missions to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants for investments in the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring.
- MedTech products – all types of medical devices related to human health.
This guidance includes information about LSIMF and the application process.
Updates to this page
Published 2 March 2022 Last updated 5 September 2025 — Show all updates
-
5 September 2025 Updates to the LSIMF privacy notice include an expanded scope of data collection and clarification on how data is collected, the purposes of processing data and the legal basis of processing.
-
31 October 2024 The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis.
-
26 February 2024 Life Sciences Innovative Manufacturing Fund (LSIMF): Phase 2 closed to applications.
-
2 May 2023 Phase 2 open to Expressions of Interest.
-
23 June 2022 Phase 1 is now closed to Expressions of Interest.
-
3 May 2022 Submit expressions of interest for Phase 1, Wave 3 by 31 May 2022, 12 noon.
-
7 April 2022 Wave 2 expressions of interest date added.
-
7 April 2022 Date for submitting expressions of interest to the LSIMF Phase 1 Wave 1 changed to Friday 29 April at 12 noon.
-
2 March 2022 First published.